The Presidential Daily Brief


  1. shutterstock 38803024

    Women’s Libido Pill Arouses New Controversy

    Addyi, or the “female Viagra,” debuted in 2015 to curiosity, criticism and stifling business entanglements. Now the drug, which purportedly treats hypoactive sexual desire disorder, is back. And so is the debate: Is the drug helping a genuine affliction or furthering misconceptions about female arousal, “disease mongering” and shaming some women into believing they’re abnormal? Critics say it’s not for pharmaceutical makers to decide what constitutes a healthy sex drive. And with its halved price and prescriptions by phone, the pink pill is sure to be on the tip of more tongues.

This story is part of The Presidential Daily Brief

view full edition